Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatches Switz Regulatory News (WOSG)

Share Price Information for Watches Switz (WOSG)

Share Price is delayed by 15 minutes
Get Live Data
713.00    -11.50 (-1.59%)
Bid:
710.00
Ask:
715.00
Spread: 5.00 (0.704%)
Market Cap: £1.65b
WOSG Live PriceLast checked at - London Stock Exchange

Intraday Watches Switz Share Chart

Q2 FY21 Trading Update

6 Oct 2020 07:00

RNS Number : 1580B
Watches of Switzerland Group PLC
06 October 2020
 

 

 

Watches of Switzerland Group PLC

Q2 FY21 Trading Update

 

Q2 performance to date stronger than expected

Full year guidance on sales and profitability revised upwards

 

Watches of Switzerland Group PLC ("the Group") today provides the following update relating to the 13 weeks ending 25 October 2020 (Q2 FY21).

 

Q2 FY21 Trading Update Highlights

· Revenue for the first 10 weeks of Q2 has been stronger than expected at £202.7 million, +20.2% in constant currency and +18.3% in reported terms, relative to the prior year

o UK performance continues to be driven by strong domestic sales offsetting lower tourist and airport business; tourist and airport sales accounted for 9.2% of Group sales in Q2 to date (Q2 FY20: 32.5% of Group sales). Regional stores continued to outperform London stores where footfall remains weak

§ Q2 sales to date of £145.1 million, +12.6% versus the prior year; within the UK, ecommerce sales +49.9%

o US momentum has further accelerated with an exceptionally strong and broad-based performance in the quarter to date

§ Q2 sales to date of £57.7 million, +43.4% in constant currency versus the prior year, +35.2% on a reported basis

· Luxury watches have continued to outperform while luxury jewellery has performed well with growth in both the UK and the US markets

· New product launches have also been stronger than anticipated with a positive influence on sales

· Continued encouraging customer response and resultant sales conversion through CRM and clientelling activities and appointment management

· New Rolex Room opened within the Watches of Switzerland Knightsbridge showroom on 18 September 2020 as part of the store's planned expansion

· Opening of a Tudor Boutique in White City London, the first in Europe, on 25 September 2020

· Acquisition of Analog Shift, US retailer of vintage and pre-owned watches to further advance the Group's strong and growing position in the US, on 1 September 2020

· Continued positive performance from the recently acquired four Fraser Hart stores

 

Outlook

· The Group revises upwards the guidance for FY21 (pre-IFRS 16 adjustments, based on a 53-week period):

o Revenue: £880.0 million to £910.0 million (previous guidance £840.0 million to £860.0 million)

o EBITDA and Adjusted EBITDA[1] margin %: +1.0% to 1.5% vs last year (previous guidance flat vs last year)

o Net debt: £80.0 million to £100.0 million (previous guidance £90.0 million to £110.0 million)

o All previous guidance remains unchanged:

§ Depreciation, amortisation, impairment and profit/loss on disposal of fixed assets: £21.0 million to £23.0 million

§ Total finance costs: £5.3 million to £5.8 million

§ Underlying tax rate: 21.0% to 22.5%

§ Capex: £28.0 million to £30.0 million

· The Group is scheduled to report half year results on 17 December 2020

 

Brian Duffy, Chief Executive Officer, said:

"We are very pleased with the strong Q2 performance we are delivering in what continue to be unprecedented market conditions. Our teams have done a fantastic job, responding positively and enthusiastically to these conditions, turning challenges into opportunities, while prioritising the health and safety of colleagues and clients.

 

Trading momentum has further improved in Q2. Stronger than anticipated UK domestic sales are offsetting lower tourist and airport traffic, whilst regional stores are continuing to outperform London stores. Furthermore, the strong momentum we have established in the US has further accelerated. All US regions are contributing to this positive trend.

 

Our guidance for the balance of the fiscal year assumes that the positive trend experienced in Q2 will be moderated by the impact of pandemic related retail disruption in the UK and the US and uncertainty in the US economy, impacting mainly in Q3. We do not assume any improvement in recent trends regarding the travel or tourist sectors.

 

Looking ahead, we will continue to focus on our strategy by investing in high quality growth through selective capital projects and targeted marketing activity."

 

 

Contacts

The Watches of Switzerland Group

Anders Romberg, CFO +44 (0) 116 2817 401

Allegra Perry, Investor Relations +44 (0) 20 7317 4600

investor.relations@thewosgroup.com 

 

Headland

Lucy Legh / Rob Walker +44 (0) 20 3805 4822

wos@headlandconsultancy.com 

 

About the Watches of Switzerland Group

The Watches of Switzerland Group is the UK's largest luxury watch retailer, operating in both the UK and US, comprising four prestigious brands; Watches of Switzerland (UK and US), Mappin & Webb (UK), Goldsmiths (UK) and Mayors (US), with complementary jewellery offering.

 

The Watches of Switzerland Group has 135 core stores across the UK and US (which includes 22 dedicated mono-brand stores in these two markets in partnership with Rolex, TAG Heuer, OMEGA and Breitling) and has a leading presence in Heathrow Airport with representation in Terminals 2, 3, 4 and 5 as well as five transactional websites.

 

The Watches of Switzerland Group is proud to be the UK's largest retailer for Rolex, Cartier, OMEGA, TAG Heuer and Breitling watches.

 

Mappin & Webb holds Royal warrants as goldsmiths, silversmiths and jeweller to Her Majesty The Queen and silversmiths to His Royal Highness The Prince of Wales. The Mappin & Webb master jeweller has been Crown Jeweller, custodian of the Crown Jewels of Her Majesty The Queen since 2012.

 

https://www.thewosgroupplc.com

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Watches of Switzerland Group PLC shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser.

 

Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

[1] Adjusted EBITDA is Earnings Before Interest, Tax, Depreciation and Amortisation and IFRS 16 impact.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKPBBOBDDDKK
Date   Source Headline
1st Jun 20264:56 pmRNSHolding(s) in Company
29th May 202610:50 amRNSHolding(s) in Company
14th May 20267:00 amRNSFY26 Trading Update
13th May 202612:09 pmRNSHolding(s) in Company
28th Apr 20264:26 pmRNSHolding(s) in Company
2nd Mar 20265:19 pmRNSDirector/PDMR Shareholding
27th Feb 202610:44 amRNSDirector/PDMR Shareholding
19th Feb 20262:00 pmRNSAppointment of Non-Executive Director
4th Feb 20267:00 amRNSQ3 FY26 Trading Update
22nd Jan 20265:01 pmRNSAcquisition of four new US showrooms
8th Dec 20255:12 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSH1 FY26 Results
2nd Dec 20257:00 amRNS-RInvestor Presentation via Engage Investor
25th Nov 20257:00 amRNSChange of Adviser
19th Nov 20254:43 pmRNSDirectorate change
17th Nov 20251:37 pmRNSHolding(s) in Company
14th Nov 20252:52 pmRNSHolding(s) in Company
7th Nov 202512:40 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSH1 FY26 Trading Update
13th Oct 20257:00 amRNSNotice of H1 trading update
4th Sep 20252:21 pmRNSDirector/PDMR Shareholding
4th Sep 20258:41 amRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
31st Jul 202511:55 amRNSAnnual Financial Report
29th Jul 20253:40 pmRNSDirector Declaration
28th Jul 202511:36 amRNSDirector/PDMR Shareholding
7th Jul 202511:37 amRNSHolding(s) in Company
3rd Jul 20257:00 amRNSFY25 Results
30th Jun 20251:41 pmRNSTotal Voting Rights
23rd Jun 20252:15 pmRNSHolding(s) in Company
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20253:04 pmRNSTotal Voting Rights
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.